We are live on ! Find out more
JDOC icon

JPMorgan Healthcare Leaders ETF

7 hedge funds and large institutions have $6.63M invested in JPMorgan Healthcare Leaders ETF in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more funds holding

Funds holding: 67 (+1)

9% more capital invested

Capital invested by funds: $6.08M → $6.63M (+$559K)

3.98% more ownership

Funds ownership: 80.25%84.23% (+4%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change

JDOC Hedge Fund Activity: Q3 2025 in Review

7 of the 7,643 institutional investors tracked by Wall St. Rank reported a position in JPMorgan Healthcare Leaders ETF (JDOC) for Q3 2025, worth a combined $6.63M — up 9.2% from $6.08M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new JDOC positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Krilogy Financial, opening a new position worth an estimated $302K. The largest seller was Jane Street, cutting an estimated $61.9K.

  • 7 institutional investors held JPMorgan Healthcare Leaders ETF (JDOC) as of Q3 2025, up from 6 in Q2 2025.
  • Funds reported $6.63M of JPMorgan Healthcare Leaders ETF stock for Q3 2025, up 9.2% quarter-over-quarter.
  • 1 fund opened new JPMorgan Healthcare Leaders ETF positions in Q3 2025 and 0 closed out, a net change of +1 holder.
  • The largest JPMorgan Healthcare Leaders ETF buyer in Q3 2025 was Krilogy Financial, an estimated $302K added.
  • The largest JPMorgan Healthcare Leaders ETF seller in Q3 2025 was Jane Street, an estimated $61.9K sold.

Based on aggregated 13F filings for Q3 2025.